Alzamend neuro announces $4 million additional investment from digital power lending upon completion of phase 1 first-in-human clinical trial for al001 treatment of dementia related to alzheimer's

Atlanta--(business wire)---- $acad #acimmune--alzamend neuro announces $4 million add'l investment by digital power lending upon completion of phase 1 clinical trial for treatment for alzheimer's
ACAD Ratings Summary
ACAD Quant Ranking